In serous ovarian carcinoma, down-regulation of PAX2 expression during later stages of tumor development in secretory cell outgrowths (SCOUTs) has been identified, and members of the TGF-β downstream signalling pathway were expressed in the same cells [38, 39]. This evidence concerns the gene PAX2 and neoplasm.